Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease

Ophthalmology

Volumn 120, Issue 6, 2013, Pages 1201-1209

  Suelves, Ana M ^a,b   Arcinue, Cheryl A ^a,b   González Martín, Jesús María ^c   Kruh, Jonathan N ^a,b   Foster, C Stephen ^a,b,d  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b Massachusetts Eye Research and Surgery Institute   (United States)

^c Statistical Results ^*  (Spain)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ALOPECIA; ARTICLE; BACTERIAL INFECTION; BASAL CELL CARCINOMA; BEST CORRECTED VISUAL ACUITY; BREAST CANCER; COHORT ANALYSIS; DISEASE CONTROL; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ELECTRONIC MEDICAL RECORD; EYE INFLAMMATION; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; INTERVENTION STUDY; LEUKOPENIA; LIVER FUNCTION TEST; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCALP TUMOR; SIDE EFFECT; VASCULITIS; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; CYCLOPHOSPHAMIDE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PULSE THERAPY, DRUG; RECURRENCE; RETINAL VASCULITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERITIS; TREATMENT FAILURE; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 84878592312     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.01.031     Document Type: Article

References (31)

1. C.S. Foster, and A.T. Vitale Diagnosis and Treatment of Uveitis 2002 Saunders Philadelphia 34-77
2. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop Am J Ophthalmol 140 2005 509 516
3. D.C. Gritz, and I.G. Wong Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study Ophthalmology 111 2004 491 500
4. C.S. Foster, and A.T. Vitale Diagnosis and Treatment of Uveitis 2002 Saunders Philadelphia 17-23
5. J.H. Chang, and D. Wakefield Uveitis: a global perspective Ocul Immunol Inflamm 10 2002 263 279
6. D.A. Jabs, J.T. Rosenbaum, and C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 2000 492 513
7. A.R. Ahmed, and S.M. Hombal Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses J Am Acad Dermatol 11 1984 1115 1126
8. N. Brock The history of the oxazaphosphorine cytostatics Cancer 78 1996 542 547
9. B. Coiffier, C. Thieblemont, and E. Van Den Neste Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de L'Adulte Blood 116 2010 2040 2045
10. K. De Groot, L. Harper, D.R. Jayne EUVAS (European Vasculitis Study Group) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial Ann Intern Med 150 2009 670 680
11. D.G. Scott, and P.A. Bacon Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis Am J Med 76 1984 377 384
12. G.G. Illei, H.A. Austin, and M. Crane Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis Ann Intern Med 135 2001 248 257
13. C.S. Yee, C. Gordon, and C. Dostal EULAR randomized controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisone followed by azathioprine and prednisolone in lupus nephritis Ann Rheum Dis 63 2004 525 529
14. J.T. Rosenbaum, J. Simpson, and C.M. Neuwelt Successful treatment of optic neuropathy in association with systemic lupus erythematous using intravenous cyclophosphamide Br J Ophthalmol 81 1997 130 132
15. I. Martin-Suarez, D. D'Cruz, and M. Mansoor Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide Ann Rheum Dis 56 1997 481 487
16. M. Saha, A.M. Powell, and B. Bhogal Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus Br J Dermatol 162 2012 790 797
17. L.P. Fox, and A.G. Pandya Pulse intravenous cyclophosphamide therapy for dermatologic disorders Dermatol Clin 18 2000 459 473
18. M. Faurschou, K. Westman, and N. Rasmussen Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 64 2012 3472 3477
19. E. Roda Perez Case of uveitis of unknown etiology treated with nitrogen mustards [in undetermined language] Rev Clin Esp 41 1951 265 267
20. S.S. Pujari, J.H. Kempen, and C.W. Newcomb Cyclophosphamide for ocular inflammatory diseases Ophthalmology 117 2010 356 365
21. K. Durrani, G.N. Papaliodis, and C.S. Foster Pulsed IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety Ophthalmology 111 2004 960 965
22. A.S. Fauci, and S.M. Wolff Wegener's granulomatosis: studies in eighteen patients and a review of the literature Medicine (Baltimore) 52 1973 535 561
23. J.T. Rosenbaum Treatment of severe refractory uveitis with intravenous cyclophosphamide J Rheumatol 21 1994 123 125
24. C. Mukhtyar, L. Guillevin, M.C. Cid European Vasculitis Study Group EULAR recommendations for the management of primary small and medium vessel vasculitis Ann Rheum Dis 68 2009 310 317
25. M. Voulgarelis, S. Giannouli, A.G. Tzioufas, and H.M. Moutsopoulos Long-term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) Ann Rheum Dis 65 2006 1033 1037
26. C.A. Deeg, B. Amann, A.J. Raith, and B. Kaspers Inter- and intramolecular epitope spreading in equine recurrent uveitis Invest Ophthalmol Vis Sci 47 2006 652 656
27. C.L. Vanderlugt, and S.D. Miller Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat Rev Immunol 2 2002 85 95
28. V.K. Salato, M.K. Hacker-Foegen, and Z. Lazarova Role of intramolecular epitope spreading in pemphigus vulgaris Clin Immunol 116 2005 54 64
29. C.D. Radis, L.E. Kahl, and G.L. Baker Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year follow-up study Arthritis Rheum 38 1995 1120 1127
30. J.H. Kempen, E. Daniel, and J.P. Dunn Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study BMJ 339 2009 b2480
31. J.H. Kempen, E. Daniel, and S. Gangaputra Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Ophthalmic Epidemiol 15 2008 47 55